510(k) device
Cochlear Baha Implant System
Cochlear Americas · Hearing Aid, Bone Conduction, Implanted (MAH, Class II) · First FDA decision Oct 12, 2012, newest Oct 12, 2012Hearing loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
12
Naming "Cochlear Baha"
MAUDE reports
0
Brand "Cochlear Baha", since 2015
PubMed studies
29
Mentioning "Cochlear Baha"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cochlear Baha Implant System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cochlear Baha", any status and sponsor, newest update first.
CochlearNot on our public-company list
NCT07130136 · 20 participants (planned) · Start Jul 24, 2026 · Primary completion Nov 2028
Device: Cochlear™ Osia® System; Cochlear™ Baha® System · For: Bone Conduction; Hearing Loss, Conductive; Hearing Loss, Mixed
Sites: London, United Kingdom; Nottingham, United Kingdom; Sheffield, United Kingdom
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cochlear Baha", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MAH
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cochlear Baha"[tiab]. The summary above synthesizes these.
- .Signal Transparency of Remote Microphone Technology in Pediatric Bone Conduction Device Users.
Sanchez C, Morgenstein K, Snapp H · Audiol Neurootol · 2023Research Support, Non-U.S. Gov't
- Auditory and Speech Outcomes Following Transcutaneous Bone Conduction Hearing Implantation.
Garrada M, Alnoury MK, AlNoury OK, et al. · Cureus · 2024
- Programmable shunt valve interactions with osseointegrated hearing devices.
J Neurosurg Pediatr · 2017
- On the evaluation of a superpower sound processor for bone-anchored hearing.
Bosman AJ, Kruyt IJ, Mylanus EAM, et al. · Clin Otolaryngol · 2018Comparative Study, Research Support, Non-U.S. Gov't
- Hearing Rehabilitation Implementing a Transcutaneous Bone Conduction Device: Single-Center Experience.
Shokri T, Czarnecki B, Baker A, et al. · Ear Nose Throat J · 2021Evaluation Study
- The impact of the Cochlearࡊ Osia® 2 System on patients with mixed or conductive hearing loss: A comparison with Cochlearࡊ Baha® Attract System outcomes.
Park KS, Kim HC, Lee S, et al. · Sci Prog · 2024Comparative Study, Research Support, Non-U.S. Gov't
- The Cochlear Baha 4 Attract System - design concepts, surgical technique and early clinical results.
Clamp PJ, Briggs RJ · Expert Rev Med Devices · 2015Clinical Trial, Multicenter Study
- Influence of Behavior on Complications of Osseointegrated Bone Conduction Devices in Children.
Kubala ME, Cox MD, Nelson KL, et al. · Otol Neurotol · 2017
- Improving the Accuracy of Baha® Fittings through Measures of Direct Bone Conduction.
Flynn MC, Hillbratt M · Clin Exp Otorhinolaryngol · 2012
- Advanced System for Implant Stability Testing (ASIST).
Westover L, Faulkner G, Hodgetts W, et al. · J Biomech · 2016
- The new Baha implant: a prospective osseointegration study.
D'Eredità R, Caroncini M, Saetti R · Otolaryngol Head Neck Surg · 2012
- Amplification of transcutaneous and percutaneous bone-conduction devices with a test-band in an induced model of conductive hearing loss.
Park MJ, Lee JR, Yang CJ, et al. · Int J Audiol · 2016Comparative Study
Other devices of this type
Also filed under product code MAH.
- Ponto Bone Anchored Hearing System, MONO Surgery KitOticon Medical AB · 510(k) 2021
- Ponto 5 MiniOticon Medical AB · 510(k) 2026
- BA310 Abutment, BIA310 Implant/AbutmentCochlear Americas · 510(k) 2018
- BA400 14mm AbutmentCochlear Americas · 510(k) 2015
- Obc Bone Anchored Hearing SystemOticon Medical AB · 510(k) 2011
- Baha Cordelle IICochlear Bone Anchored Systems AB · 510(k) 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.